Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)
- Conditions
- Chronic Symptomatic Functional Tricuspid RegurgitationTricuspid Valve InsufficiencyHeart Valve Disease
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2018-02-07
- Lead Sponsor
- Mitralign, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT03225612
- Locations
- 🇩🇪
Vivantes Klinikum Am Urban, Berlin, Germany
🇩🇪Herzzentrum Brandenburg in Bernau, Bernau bei Berlin, Germany
🇩🇪CardioVascular Center Frankfurt, Frankfurt, Germany
Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.
- Conditions
- Heart Valve DiseaseTricuspid Valve InsufficiencyChronic Symptomatic Functional Tricuspid Regurgitation
- First Posted Date
- 2015-10-14
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- Mitralign, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02574650
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Kaiser Permanente, San Francisco, California, United States
🇺🇸MedStar Washington Hospital Center, Washington, D.C., District of Columbia, United States
Mitralign Percutaneous Annuloplasty First in Man Study
- Conditions
- Functional Mitral Regurgitation
- First Posted Date
- 2013-05-13
- Last Posted Date
- 2016-03-18
- Lead Sponsor
- Mitralign, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT01852149
- Locations
- 🇧🇷
Instituto Dante Passanese de Cardiologia, Sao Paulo, Brazil
🇩🇪Universitats Klinikum Bonn, Bonn, Germany
🇩🇪Elisabeth-Krankenhaus Essen, Essen, Germany
Mitralign Percutaneous Annuloplasty System for Chronic Functional Mitral Valve Regurgitation
- Conditions
- Mitral Valve Regurgitation
- First Posted Date
- 2012-12-04
- Last Posted Date
- 2016-10-17
- Lead Sponsor
- Mitralign, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT01740583
- Locations
- 🇨🇴
Clinica CardioVID, Medellin, Antioquia, Colombia
🇨🇴Antonio Dager, MD, Valle del Cauca, Cali, Colombia
🇫🇷Bordeaux Heart University Hospital, Bordeaux-Pessac, France